Is Harte Hanks Inc (HHS) A Good Stock To Buy?

Now that we’ve mentioned the most bullish investors, let’s also take a look at some funds that cut their entire stakes in the stock during the third quarter. At the top of the heap, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital cut the largest stake of the 700 funds monitored by Insider Monkey, valued at an estimated $0.5 million in stock, and Ben Levine, Andrew Manuel and Stefan Renold’s LMR Partners was right behind this move, as the fund sold off about $0.1 million worth of shares.

Let’s now take a look at hedge fund activity in other stocks similar to Harte Hanks Inc (NYSE:HHS). These stocks are CARDIOME PHARMA CORP (NASDAQ:CRME), Destination Maternity Corp (NASDAQ:DEST), Digirad Corporation (NASDAQ:DRAD), and Hydra Industries Acquisition Corp. (NASDAQ:HDRA). This group of stocks’ market values are similar to HHS’s market value.

As you can see these stocks had an average of 7 hedge funds with bullish positions and the average amount invested in these stocks was $18 million. That figure was $5 million in HHS’s case. CARDIOME PHARMA CORP (NASDAQ:CRME) is the most popular stock in this table. On the other hand Hydra Industries Acquisition Corp. (NASDAQ:HDRA) is the least popular one with only 5 bullish hedge fund positions. Compared to these stocks Harte Hanks Inc (NYSE:HHS) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None